>
Switch to:

Indaptus Therapeutics Price-to-Tangible-Book

: 2.85 (As of Today)
View and export this data going back to 2021. Start your Free Trial

As of today (2021-10-28), Indaptus Therapeutics's share price is $7.3503. Indaptus Therapeutics's Tangible Book per Share of Jun. 2021 for the quarter that ended in Jun. 2021 was $2.58. Hence, Indaptus Therapeutics's Price to Tangible Book Ratio of today is 2.85.

The historical rank and industry rank for Indaptus Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

NAS:INDP' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0   Med: 0   Max: 2.9
Current: 2.85

0
2.9

During the past 0 years, Indaptus Therapeutics's highest Price to Tangible Book Ratio was 2.90. The lowest was 0.00. And the median was 0.00.

NAS:INDP's Price-to-Tangible-Book is ranked lower than
99.99% of the 250 Companies
in the Biotechnology industry.

( Industry Median: 4.88 vs. NAS:INDP: 2.85 )

A closely related ratio is called PB Ratio. As of today, Indaptus Therapeutics's share price is $7.3503. Indaptus Therapeutics's Book Value per Sharefor the quarter that ended in Jun. 2021 was $2.58. Hence, Indaptus Therapeutics's P/B Ratio of today is 2.85.


Indaptus Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Indaptus Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indaptus Therapeutics Annual Data
Trend
Price-to-Tangible-Book

Indaptus Therapeutics Quarterly Data
Jun20 Mar21 Jun21
Price-to-Tangible-Book - - -

Competitive Comparison

For the Biotechnology subindustry, Indaptus Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Indaptus Therapeutics Price-to-Tangible-Book Distribution

For the Biotechnology industry and Healthcare sector, Indaptus Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Indaptus Therapeutics's Price-to-Tangible-Book falls into.



Indaptus Therapeutics Price-to-Tangible-Book Calculation

Indaptus Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2021 )
=7.3503/2.578
=2.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Indaptus Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Indaptus Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Indaptus Therapeutics Business Description

Indaptus Therapeutics logo
Industry
Healthcare » Biotechnology NAICS : 541714 SIC : 2834
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)